NO20060510L - Emulgerende systemer inneholdende azetidinderivater - Google Patents

Emulgerende systemer inneholdende azetidinderivater

Info

Publication number
NO20060510L
NO20060510L NO20060510A NO20060510A NO20060510L NO 20060510 L NO20060510 L NO 20060510L NO 20060510 A NO20060510 A NO 20060510A NO 20060510 A NO20060510 A NO 20060510A NO 20060510 L NO20060510 L NO 20060510L
Authority
NO
Norway
Prior art keywords
systems containing
azetidine derivatives
emulsifying systems
containing azetidine
derivatives
Prior art date
Application number
NO20060510A
Other languages
English (en)
Inventor
Maria-Teresa Peracchia
Sophie Cote
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20060510L publication Critical patent/NO20060510L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Det er beskrevet emulgerende systemer inneholdende azetidinderivater. Det er videre beskrevet nye formuleringer av azetidinderivater for oral administrering.
NO20060510A 2003-07-18 2006-01-31 Emulgerende systemer inneholdende azetidinderivater NO20060510L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (en) 2003-07-18 2003-07-18 Emulsifying systems containing azetidine derivatives
PCT/EP2004/008552 WO2005013972A1 (en) 2003-07-18 2004-07-08 Emulsifying systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
NO20060510L true NO20060510L (no) 2006-01-31

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060510A NO20060510L (no) 2003-07-18 2006-01-31 Emulgerende systemer inneholdende azetidinderivater

Country Status (31)

Country Link
US (1) US20050037062A1 (no)
EP (2) EP1498123A1 (no)
JP (1) JP2009513559A (no)
KR (1) KR20060040690A (no)
CN (1) CN1822830A (no)
AR (1) AR045912A1 (no)
AU (1) AU2004262497A1 (no)
BR (1) BRPI0412239A (no)
CA (1) CA2532668A1 (no)
CR (1) CR8178A (no)
EC (1) ECSP066291A (no)
GT (1) GT200400134A (no)
HR (1) HRP20060021A2 (no)
IL (1) IL173113A0 (no)
MA (1) MA27921A1 (no)
MX (1) MXPA06000478A (no)
MY (1) MY142076A (no)
NO (1) NO20060510L (no)
NZ (1) NZ544707A (no)
OA (1) OA13190A (no)
PA (1) PA8606601A1 (no)
PE (1) PE20050699A1 (no)
RS (1) RS20050971A (no)
RU (1) RU2348615C2 (no)
SG (1) SG144140A1 (no)
TN (1) TNSN06012A1 (no)
TW (1) TW200522946A (no)
UA (1) UA82539C2 (no)
UY (1) UY28422A1 (no)
WO (1) WO2005013972A1 (no)
ZA (1) ZA200600489B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
CN101346128B (zh) * 2005-10-25 2013-10-02 雅培制药有限公司 包含低水溶解度药物的配方及其使用方法
KR20090075844A (ko) * 2006-09-29 2009-07-09 플루로메드, 인코포레이티드 쇄석술 동안 결석 및 단편 역류를 방지하는 방법
WO2009024590A2 (en) * 2007-08-21 2009-02-26 Basilea Pharmaceutica Ag Antifungal composition
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
US9918965B2 (en) * 2015-04-10 2018-03-20 Bioresponse, L.L.C. Self-emulsifying formulations of DIM-related indoles
CN111759823B (zh) * 2015-09-17 2022-12-30 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
RU2019138507A (ru) 2017-05-02 2021-06-02 Мерк Шарп И Доум Корп. Составы антител против lag3 и совместные составы антител против lag3 и антител против pd-1
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
WO2022259205A1 (en) * 2021-06-11 2022-12-15 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
HRP20060021A2 (en) 2006-02-28
GT200400134A (es) 2005-02-22
AR045912A1 (es) 2005-11-16
TW200522946A (en) 2005-07-16
CN1822830A (zh) 2006-08-23
MXPA06000478A (es) 2006-04-05
ECSP066291A (es) 2006-07-28
EP1498123A1 (en) 2005-01-19
PA8606601A1 (es) 2005-03-03
RU2006105000A (ru) 2006-07-10
UA82539C2 (en) 2008-04-25
RU2348615C2 (ru) 2009-03-10
TNSN06012A1 (en) 2007-10-03
AU2004262497A1 (en) 2005-02-17
MA27921A1 (fr) 2006-06-01
ZA200600489B (en) 2007-04-25
IL173113A0 (en) 2006-06-11
US20050037062A1 (en) 2005-02-17
CA2532668A1 (en) 2005-02-17
WO2005013972A1 (en) 2005-02-17
AU2004262497A2 (en) 2005-02-17
SG144140A1 (en) 2008-07-29
RS20050971A (en) 2008-06-05
BRPI0412239A (pt) 2006-09-12
KR20060040690A (ko) 2006-05-10
PE20050699A1 (es) 2005-09-15
OA13190A (en) 2006-12-13
CR8178A (es) 2007-12-04
EP1648441A1 (en) 2006-04-26
UY28422A1 (es) 2005-02-28
NZ544707A (en) 2009-01-31
JP2009513559A (ja) 2009-04-02
MY142076A (en) 2010-08-30

Similar Documents

Publication Publication Date Title
NO20060510L (no) Emulgerende systemer inneholdende azetidinderivater
CY1116372T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
NO20050828L (no) lndol-3-svovelderivater
NO20056130L (no) Nye substituerte 3-svovelindoler
NO20052761L (no) Spirocykliske cykloheksanderivater.
CO5590918A2 (es) Formulaciones
NO20054762L (no) Polymorphs of aripiprazole
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
DE602004031410D1 (de) Inden derivate als pharmazeutika
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
NO20060509L (no) Halvfaste systemer inneholdende azetidinderivater
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
GB0308201D0 (en) Novel compounds
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SE0300104D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
WO2004093796A3 (en) Lactam derivatives and methods of their use
ATE394386T1 (de) 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren
MXPA05012117A (es) Derivados de diarilmetiliden piperidina, preparaciones de los mismos y usos de los mismos.
SE0300987D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
BR0312734A (pt) Composto de indolina e uso medicinal do mesmo
SE0301441D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301443D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application